| Education | |||
| B.S. | 1963 | UCLA | Zoology |
| M.S. | 1965 | University of Illinois | Chemistry |
| Ph.D. | 1968 | University of Washington | Biochemistry |
| Positions held | |
| July, 1994 - | Professor and Chair, emeritus, UCLA |
| Feb-April, 1997 | Michaels Visiting Professor Weizmann Institute of Science, Rehovot, Israel |
| July, 1989 - June, 1996 | Chair, Department of Molecular, Cell and Developmental Biology, UCLA |
| July, 1978 - June, 1994 | Professor of Immunology, UCLA |
| July, 1972 - June, 1994 | Member, Molecular Biology Institute, UCLA |
| July, 1983 - June, 1984 | Visiting Scholar, INSERM/CNRS, Marseille |
| July, 1978 - June, 1989 | Associate Director, Molecular Biology Institute, UCLA |
| July, 1977 - June, 1978 | Visiting Scholar, Stanford University |
| July, 1975 - June, 1988 | Head, Parvin Cancer Research Laboratories, UCLA |
| July, 1975 - June, 1978 | Assistant Director, UCLA Cancer Center |
| July, 1974 - June, 1978 | Associate Professor of Immunology, UCLA |
| July, 1970 - June, 1974 | Assistant Professor of Immunology, UCLA |
Honors and Awards
NIH Career Development Award, 1975-1980
Professional Societies
American Association of Immunologists
Biophysical Society
Transplantation Society
New York Academy of Sciences
Professional Presentations Since 1996
10/23/96 Halifax,
Nova Scotia "The
Role of Cytotoxic Pathways in Canadian
Transplant Society Allograft
Rejection." 11/22/96 Washington,
DC "Sex
and the Origins of Death" Smithsonian
Institution 1/29/97 New
York City "Sex
and the Origins of death" American
Museum of Natural History 3/27/97 Rehovot,
Israel "The
Role of Cytotoxic Pathways Weizmann
Institute of Science
in Allograft Rejection" 8/30/97 Davis,
CA "Sex
and the Origins of Death" German-US
Aging Workshop 9/30/97 Sion,
Switzerland "Life
and Death in Evolution" Emergence
Workshop 10/17/97 Toulouse,
France "Sex
and the Origins of Death" Human
Genetics Institute (CNRS-Purpan) 2/9/98 Los
Angeles, CA "Evolution
of Senescence and Death" UCLA
Gerontology Research Group 10/7/98 Los
Angeles City Library "The
Baltimore Case" (moderator) 12/8/99 Institute
for Theoretical "Sex
and the Origins of Death" Physics,
UCSB 12/15/99 Medicine
for the New "Cell
& Molecular Basis of Aging" Millennium,
Las Vegas 6/16/00 Evolution
Club, UCLA "Sex
and the Origins of Death" 4/2/01 Behavior,
Evolution and Culture Discussion
Group, UCLA "Sex
and the Origins of Death" 9/13/01 Plato
Society, Los Angeles "Are
We Hardwired?" 4/17/04 Bowen Center, Georgetown "The Immune System and Disease" |
Books and Monographs
|
Berke, G. and W. R. Clark. 2005. Killer Lymphocytes. Elsevier, In Press Clark, W.R, and M. Grunstein. 2000. Are We Hardwired: The Role of Genes in Human Behavior. Oxford University Press, New York. Clark, W. R. 1999. A Means to an End: The Biological Basis of Aging and Death. Oxford University Press, New York. Clark, W. R. 1997. The New Healers: The Promise and Problems of Molecular Medicine in the Twenty-first Century. Oxford University Press, New York. Clark, W.R. Sex and the Origin of Death. 1996. Oxford University Press, New York. Clark, W.R. 1995. At War Within: The Double-Edged Sword of Immunity. Oxford University Press, New York. Clark, W.R. 1990. The Experimental Foundations of Modern Immunology. John Wiley and Sons, New York. (Fourth Edition.) Clark, W.R. 1986. The Experimental Foundations of Modern Immunology. John Wiley and Sons, New York. (Third Edition.) Clark, W.R. 1983. The Experimental Foundations of Modern Immunology. John Wiley and Sons, New York. (Second Edition.) Clark, W.R. 1980. The Experimental Foundations of Modern Immunology. John Wiley and Sons, New York. Clark, W.R. and Golstein, P. (Eds.) 1982. Mechanisms of Cell-Mediated Cytotoxicity. Advances in Experimental Biology and Medicine, Vol. 146. Plenum Press, New York, 1982. Clark, W.R. (Editor). Prevention of Rejection of Transplanted Pancreas or Islets. Diabetes 31/Suppl. 1 (1982). |
RESEARCH PUBLICATIONS
|
1. Rutter,
W.J., Ball, W.D., Bradshaw, W.S., Clark, W.R., and Sanders, T.G. Morphological and molecular analogy in
cytodifferentiation. In Secretory
Mechanisms of Salivary Glands, L.H. Schneyer and C.A. Schneyer, Eds.,
Academic Press, New York, pp. 238-253 (1967). 2. Rutter, W.J., Ball, W.D., Bradshaw, W.S.,
Clark, W.R., and Sanders, T.G.
Levels of regulation in cytodifferentiation. In Experimental Biology and Medicine, Vol. I., S.
Karger, Basel/New York, pp. 110-124 (1967). 3. Rutter,
W.J., Clark, W.R., Kemp, J.D., Bradshaw, W.S., Sanders, T.G., and Ball, W.D.
Multiphasic regulation in cytodifferentiation. In Epithelial-Mesenchymal Interactions. Raul
Fleischmajor and R.E. Billingham, Eds., Williams and Wilkins, Baltimore, pp.
114-131 (1968). 4. Rutter,
W.J., Kemp, J.D., Bradshaw, W.S., Clark, W.R., Ronzio, R.A., and Sanders, T.G.
Regulation of specific protein synthesis in cytodifferentiation. Journal of Cellular Physiology 72:1-18
(1968). 5. Berke, G., Clark,
W.R., Altman, A., and Feldman, M.
Comparative study of in vivo
and in vitro
heterograft reactions. Israel
Journal of Medical Sciences 6:454 (1970). 6. Lonai, P., Clark,
W.R., and Feldman, M.
Participation of th-bearing cell in an in vitro assay of transplantation immunity. Nature 229:566-567
(1971). 7. Clark, W.R., Berke,
G., Feldman, M., and Sarid, S.
Macromolecular synthesis during the sensitization of rat lymphocytes on
mouse fibroblasts in vitro. Immunochemistry 8:487-498
(1971). 8. Berke, G., Clark,
W.R., and Feldman, M. In vitro induction of a heterograft reaction.
Immunological parameters of the sensitization of rat lymphocytes against mouse
cells in vitro. Transplantation 12:237-248
(1971). 9. Clark, W., and
Kimura, A. Immunoreactivity in a
cellular immune reaction of lymphocytes preabsorbed on cell monolayers. Nature New Biology 235:236-238
(1972). 10. Pictet, R.L., Clark, W.R., Williams,
R.H., and Rutter, W.J. An
ultrastructural analysis of the developing embryonic pancreas. Developmental Biology 29:436-467
(1972). 11. Clark, W.R., and Rutter, W.J. Synthesis and accumulation of insulin
in the fetal rat pancreas. Developmental
Biology 29:468-481 (1972). 12. Blachman, U., Clark, W.R., and
Pickett, M.J. Radiobacteriolysis:
A new technique using chromium-51 for assaying anti-vibrio cholerae antibodies. Infection and Immunity 7:53-61 (1973). 13. Clark, W.R., and Kimura, A.K. Effect of monolayer fractionation of
lymphocytes on graft-versus-host reactivity. Transplantation 16:110-116 (1973). 14. Clark, W., and Nedrud, J. Effect of BUdR on proliferation and
development of cytotoxicity in mixed leukocyte culture. Cellular Immunology 10:159-164
(1974). 15. Kimura, A.K., and Clark, W.R. Functional characteristics of T cell
receptors during sensitization against histocompatibility antigens in vitro.
Cellular Immunology 12:127-139 (1974). 16. Brown, J., Molnar, I.G., Clark, W.,
and Mullen, Y. Control of
experimental diabetes mellitus in rats by transplantation of fetal
pancreases. Science 184:1377-1379
(1974). 17. Clark, W.R. An antigen-specific component of lectin-mediated
cytotoxicity. Cellular
Immunology 17:505-516 (1975). 18. Nedrud, J., Touton, M., and Clark,
W.R. The requirement for DNA
synthesis and gene expression in the generation of cytotoxicity in vitro.
Journal of Experimental Medicine 142:960-972 (1975). 19. Clark, W., Nedrud, J., Touton, M.,
and Knoeber, L. Early events in
the generation of antigen-specific cytotoxicity in MLC. Advances in Experimental Medicine
and Biology 66:355-360 (1975). 20. Brown, J., Clark, W.R., Molnar, I.G.,
and Mullen, Y.S. Fetal pancreas
transplantation for reversal of streptozotocin-induced diabetes in rats. Diabetes 25:56-64
(1976). 21. Heininger, D., Touton, M.,
Chakravarty, A.K., and Clark W.R. Activation
of cytotoxic function in T lymphocytes.
Journal of Immunology 117:2175-2180 (1976). 22. Mullen, Y.S., Clark, W.R., Molnar,
I.G., and Brown, J. Complete
reversal of experimental diabetes mellitus in rats by a single fetal
pancreas. Science 195:68-70
(1977). 23. Knoeber, L.L., and Clark, W. Temporal requirement for antigen in
primary and secondary MLC reactions.
Transplantation 24:10-15 (1977). 24. Kemp, J.A., Mazur, P., Mullen, Y.,
Miller, R.H., Clark, W., and Brown, J.
Reversal of experimental diabetes by fetal rat pancreas. I. Survival and
function of fetal rat pancreas frozen to -196EC. Transplantation Proceedings 9:325-328
(1977). 25. Mullen, Y., Clark, W.R., Kemp, J.,
Molnar, I.G., and Brown, J.
Reversal of experimental diabetes by fetal rat pancreas. II. Critical
procedures for transplantation. Transplantation Proceedings 9:329-332
(1977). 26. Chakravarty, A.K., and Clark,
W.R. Lectin-driven maturation of
cytotoxic effector cells: The
nature of effector memory. Journal
of Experimental Medicine 146:230-240 (1977). 27. Clark, W.R., Heininger, D., Touton,
M., and Chakravarty, A.K.
Regeneration of effector function in vitro. Proceedings of the 11th
Leukocyte Culture Conference, pp. 650-652 (1977). 28. Brown, J., Clark, W., Molnar, I.G.,
Kemp, J., Mazur, P., and Mullen, Y.S.
Functional capacity and cryopreservation of fetal rat pancreas in
streptozotocin-diabetes. In Proceedings
of the 9th Congress of International Diabetes, FEBS. J.S. Bajaj,
Ed., Excerpta Medica, pp. 167-175 (1977). 29. Thoma, J.A., Touton, M.H., and Clark,
W.R. Interpretation of 51Cr-release
data: A kinetic analysis. Journal of Immunology 120:991-997
(1978). 30. Kedar, E., Clark, W.R., and Bonavida,
B. In vivo and in vitro induction of cytotoxic lymphocytes by
alloantigen-reactive lymphocytes fractionated on spleen cell monolayers. Transplantation 25:146-151
(1978). 31. Touton, M.H., and Clark, W.R. Progressive changes in cytotoxic
potential during mixed lymphocyte culture. Journal of Immunology 120:1537-1543 (1978). 32. Mandel, G., Shimizu, S., Gill, R.,
and Clark, W. Alteration of the
fatty acid composition of membrane phospholipids in mouse lymphoid cells. Journal of Immunology 120:1631-1636
(1978). 33. Mandel, G., and Clark, W. Functional properties of EL-4 tumor
cells with lipid-altered membranes.
Journal of Immunology 120:1637-1643 (1978). 34. Clark, W.R. Ontogeny of T cell function: Generation of cytotoxic
function in T cells as a model for terminal cell differentiation. Development and Comparative
Immunology 2:393-408 (1978). 35. Kemp, J.A., Mullen, Y., Weisman, H.,
Heininger, D., Brown, J., and Clark, W.R. Reversal of diabetes in rats using
fetal pancreases stored at -196EC.
Transplantation 26:260-264 (1978). 36. Thoma, J.A., Thoma, G.J., and Clark,
W. The efficiency and linearity of
the radiochromium release assay for cell-mediated cytotoxicity. Cellular Immunology 40:404-418
(1978). 37. Brown, J., Clark, W.R., Makoff, R.K.,
Weisman, H., Kemp, J.A., and Mullen, Y. Pancreas transplantation for diabetes
mellitus. Annals of Internal
Medicine 89:951-965 (1978). 38. Clark, W., and Gill, R. Effect of membrane lipid composition on
immune cells function. In Twelfth
International Leukocyte Culture Conference. M. Quastel, Ed., Academic
Press, New York, pp. 613-619 (1979). 39. Hurt, S.N., Berke, G., and Clark,
W. A rapid method for generating
cytotoxic effector cells in vivo. Journal of Immunological Methods 28:321-329
(1979). 40. Smith, B.A., Clark, W.R., and
McConnell, H.M. Anisotropic
molecular motion on cell surfaces.
Proceedings of the National Academy of Sciences USA 76:5641-5644
(1979). 41. Brown, J., Mullen, Y., Clark, W.R.,
Molnar, I.G., and Heininger, D.
Importance of hepatic portal circulation for insulin action in
streptozotocin-diabetic rats transplanted with fetal pancreases. Journal of Clinical Investigation 64:1688-1694
(1979). 42. Brown, J., Kemp, J.A., Hurt, S., and
Clark, W.R. Cryopreservation of
human fetal pancreas. Diabetes
29:70-73
(1980). 43. Gill, R., and Clark, W. Membrane structure-function
relationships in cell-mediated cytolysis. I. Effect of exogenously incorporated
fatty acids on effector cell function in cell-mediated cytolysis. Journal of Immunology 125:689-695 (1980). 44. Kemp, J.A., Hurt, S.N., Brown, J.,
and Clark, W.R. Recovery and
function of human fetal pancreas frozen to -196EC. Transplantation 32:10-15 (1981). 45. McVey, E., Yguerabide, J., Hanson,
D.C., and Clark, W.R. The
relationship between plasma membrane lipid composition and physical-chemical
properties. I. fluorescence polarization studies of fatty acid-altered EL-4
tumor cell membranes. Biochimica
et Biophysica Acta 642:106-118 (1981). 46. Berke, G., Hu, V., McVey, E., and
Clark, W.R. T-Lymphocyte-mediated
cytolysis. I. A common mechanism for target recognition in specific and
lectin-dependent cytolysis. Journal of Immunology 127:776-781
(1981). 47. Berke, G., McVey, E., Hu, V., and
Clark, W.R. T lymphocyte-mediated
cytolysis. II. Role of target cell histocompatibility antigens in recognition
and lysis. Journal of Imunology 127:782-787
(1981). 48. Hu, V., and Clark, W.R. The role of major histocompatibility
complex proteins in the generation and expression of cell-mediated cytotoxicity. In Developmental Immunology:
Clinical Problems and Aging. E. Cooper, Ed., Academic Press, pp. 263-268
(1982). 49. Berke, G., Hu, V., McVey, E., and
Clark, W. A common role for target
cell histocompatibility antigens in both nonspecific and specific T
lymphocyte-mediated cytolysis. Journal
of Cellular Biochemistry 18:337-349 (1982). 50. Berke, G., and Clark, W. How cytotoxic T lymphocytes lyse target
cells: A Theory. In Mechanisms
of Lymphocyte Activation/Proceedings of the 14th International
Leukocyte Conference. K. Resch and H. Kirchner, Eds., Elsevier/North
Holland Biomedical Press, Amsterdam, pp. 439-441 (1981). 51. Poon, R., Richards, J.M., and Clark,
W.R. The relationship between
plasma membrane lipid composition and physical-chemical properties. II. Effect
of phospholipid fatty acid modulation on plasma membrane physical properties
and enzymatic activities. Biochimica
et Biophysica Acta 649:58-66 (1981). 52. Berke, G., and Clark, W.R. T lymphocyte-mediated cytolysis - A
comprehensive theory. I. The mechanism of CTL-mediated cytolysis. Advances in Experimental Biology and
Medicine 146:57-68 (1982). 53. Clark, W.R., and Berke, G. T lymphocyte-mediated cytolysis - a
comprehensive theory. II. Lytic vs. nonlytic interactions of T lymphocytes. Advances in Experimental Biology and
Medicine 146:69-73 (1982). 54. Poon, R., and Clark, W.R. The relationship between plasma
membrane lipid composition and physical-chemical properties. III. Detailed
physical and biochemical analysis of fatty acid-substituted EL-4 plasma
membrane. Biochimica et
Biophysica Acta 689:230-240 (1982). 55. Makoff, R.K., Brown, J., Mullen, Y.,
and Clark, W.R. Normalization of
six key hepatic enzymes after fetal pancreas transplantation in diabetic
rats. Diabetes 32:730-733
(1983). 56. Danilovs, J.A., Brown, J., Terasaki,
P.I., and Clark, W.R. HLA-DR and
HLA-A,B,C typing of human fetal tissue.
Tissue Antigens 21:296-308 (1983). 57. Bialick, R., Gill, R., Berke, G., and
Clark, W.R. Modulation of cell-mediated
cytotoxicity function after alteration of fatty acid composition in vitro.
Journal of Immunology 132:81-87 (1984). 58. Brown, J., Danilovs, J.A., Clark,
W.R., and Mullen, Y.S. Fetal
pancreas as a donor organ. World
Journal of Surgery 8:152-157 (1984). 59. Kane, K., and Clark, W.R. The role of class I MHC products in
polyclonal activation of CTL function.
Journal of Immunology 133:2857-2863 (1984). 60. Brown, J., Clark, W.R., Danilovs,
J.A., and Mullen, Y.S.
Cryopreservation of the fetal pancreas. In Methods in Diabetes Research, Vol. I. J. Larner
and S.L. Pohl, Eds., John Wiley and Sons, Inc., pp. 317-324 (1984). 61. Brunet, J.-F., Dosseto, M., Denizot,
F., Mattei, M.-G., Clark, W.R., Haqqi, T.M., Ferrier, P., Nabholz, M.,
Schmitt-Verhulst, A.-M., Luciani, M.-F., and Golstein, P. The inducible cytotoxic
T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization
to mouse chromosome 14. Nature 322:268-271
(1986). 62.Torbett, B.E., Skidmore, B., and
Clark, W.R. Multiple pathways for
antigen-independent activation of a T helper hybridoma. European Journal of Immunology 16:933-938 (1986). 63. Kane, K.P., and Clark, W.R. Class I MHC antigens in the generation
and expression of promiscuous cytotoxic cell function. Journal of Immunology 137:3080-3086
(1986). 64. Gorman, K.C., Kane, K.P., and Clark,
W.R. Target cell recognition
structures in LDCC and ODCC. Journal
of Immunology 138:1014-1019 (1987). 65. Blakely, A., Gorman, K.C.,
Ostergaard, H., Svoboda, K., Liu, C.-C., Young, J. D.-E., and Clark, W.R. Resistance of cloned cytotoxic T
lymphocytes to cell-mediated cytotoxicity. Journal of Experimental Medicine 166:1070-1083
(1987). 66. Shiogama, T., Mullen, Y., Klandors,
H., Terada, M., and Clark, W.R. An
improved cryopreservation procedure for human fetal pancreas tissues. Transplantation 44:602-607
(1987). 67. Ostergaard, H., and Clark, W.R. The role of Ca2+ in
activation of mature cytotoxic T lymphocytes for lysis. Journal of Immunology 139:3573-3579
(1987). 68. Ostergaard, H.L., Kane, K.P.,
Mescher, M.F., and Clark, W.R.
Cytotoxic T lymphocyte- mediated lysis without release of serine
esterase. Nature 330:71-72
(1987). 69.
Brunet, J.-F., Denizot, F., Dosseto, M., Suzan, M., Clark, W.R., Haqqi,
T.M., Luciani, M.-F., and Golstein, P.
A molecular biology approach to the mechanism of T-cell-mediated
cytotoxicity. Ann. De LÕInst.
Pasteur/Immunology 138:331-336 (1987) 70.
Young, J.D.-E., Clark, W.R., Liu, C.-C., and Cohn, Z.A. A calcium- and perforin-independent
pathway of killing mediated by murine cytolytic lymphocytes. Journal of Experimental Medicine
166:1894-1899
(1987). 71.
Gorman, K., Liu, C.-C., Blakely, A., Young, J. D.-E., Torbett, B.E, and
Clark W.R. Cloned cytotoxic T
lymphocytes as target cells. II. Polarity of lysis revisited. Journal of Immunology 141:2211-2215
(1988). 72.
Ostergaard, H., Gorman, K., and Clark, W.R. Cloned cytotoxic T lymphocyte target cells fail to induce
early activation events in effector cytotoxic T lymphocytes. Cellular Immunology 114:188-197
(1988). 73.
Torbett, B.E, and Clark, W.R.
The role of accessory molecules in T-helper activation induced by
antigen, lectin or CD3 antibodies.
Cellular Immunology 115:352-362 (1988). 74.
Clark, W.R. Perforin - a
primary or auxilliary lytic mechanism?
Immunology Today 9:101-104 (1988). 75.
Clark, W., Ostergaard, H., Gorman, K., and Torbett, B. Molecular mechanisms of CTL-mediated
lysis: a cellular perspective. Immunological
Reviews 103:37-51 (1988). 76.
Ostergaard H.L., and Clark, W.R.
Evidence for Multiple Lytic Pathways Used by Cytotoxic T
Lymphocytes. Journal of
Immunology 143:2120-2126 (1989). 77.
Redei, E., Clark, W. R., and McGivern, R. F. Alcohol exposure in utero results in diminished T-cell
function and alterations in brain corticotropin-releasing factor and ACTH
content. Alcoholism: Clinical
and Experimental Research 13:439-443
(1989). 78. Joag, S.V., Liu, C.-C., Kwon, B.S.,
Clark, W.R., and Young, J.D.-E.
Expression of mRNAs for
pore-forming protein and two serine esterases in murine primary and cloned
effector lymphocytes. Journal
of Cell Biochemistry 43:81-88 (1990). 79. Soon-Shiong, P., Lu, Z.N., Grewal,
I., Lanza, R.P., and Clark, W. An
in vitro method of assessing the immunoprotective properties of microcapsule
membranes using pancreatic and tumor cell targets. Transplantation Proceedings 22:754-755
(1990). 80. Ratner, A., and Clark, W.R. Lack of target cell participation in
cytotoxic T lymphocyte-mediated lysis.
Journal of Immunology 147:55-59 (1991). 81. Clark, W.R. Prevention of anesthesia-induced immunosuppression: A novel
strategy involving interferons. Anesthesiology 78:627-628
(1992). 82. Ratner, A., and Clark, W.R. Role of TNF-a in acute CD8 cytotoxic T
lymphocyte-mediated lysis. Journal of Immunology 150:4303-4314 (1993). 83. Kim, K-K., Blakely, A., Zhou, Z.,
Davis, J., Clark, W., and Kwon, B.S.
Changes in the level of perforin and its transcript during effector and
target cell interactions. Immunological
Letters 36:161-170 (1993). 84. Clark, W.R. and Ratner, A. Multiple lytic pathways in cytotoxic T
lymphocyte. In Cytotoxic Cells:
Recognition, Effector Function, Generation, and Methods, Sitkovsky, M.V., and Henkart, P.A. eds.,
Chapter. 16, pp.178-189 (1993). 85. Clark, W.R. The hole truth about perforin. Nature
369:16-17 (1994). 86. Walsh, C.M., Glass, A.A., Chiu, V.,
and Clark, W.R. The role of the fas lytic pathway in a perforin-less CTL
hybridoma. Journal of Immunology 153:2506-2514 (1994). 87. Walsh, C.M., Matloubian, M., Liu,
C.-C., Ueda, R., Kurahara, C.G., Christensen, J.L., Huang, M.T.F., Young,
J.D.-E, Ahmed, R. and Clark, W.R.
Immune function in mice lacking the perforin gene. Proceedings of the National Academy
of Sciences USA 91:10854-10858 (1994). 88. Chiu, V.K., Walsh, C.M., Lui, C.-C.,
and Clark, W.R. bcl-2 blocks degranulation- but not fas-based cell-mediated cytotoxicity. Journal of Immunology 154:2023-2032 (1995). 89. Clark, W.R., Walsh, C.M., Glass,
A.A., Huang, M.T.F., Ahmed, R., and Matloubian, M. Cell-mediated cytotoxicity in perforin-less mice. International Reviews of Immunology
13:1-14
(1995). 90. Liu, C.-C., Walsh, C.M., Eto, N.,
Clark, W.R., and Young, J.D.-E.
Morphological and functional characterization of perforin-deficient
lymphokine activated killer cells.
Journal of Immunology 155:602-608 (1995). 91. Clark, W.R., Walsh, C.M., Glass,
A.A., Hayashi, F., Matloubian, M., and Ahmed, R. Molecular pathways of
CTL-mediated cytotoxicity. Immunological
Reviews 146:33-44 (1995). 92. Clark, W.R, Walsh, C.M., Matloubian,
M., Glass, A., Hayashi, F., and Ahmed, R.
Mechanisms of CTL-Mediated Cytotoxicity. Seminars in Virology 7:113-116 (1996). 93. Walsh, C.M., Hayashi, F., Saffron,
D.C., Ju, S.-T., Berke, G., and Clark, W.R. Cell-mediated cytotoxicity results from, but may not be
critical for, primary allograft rejection. Journal of Immunology 156:1436-1441 (1996). 94. Glass, A.A., Walsh, C.M., Lynch, D.,
and Clark, W.R. Regulation of the fas lytic pathway in cloned cytotoxic T
lymphocytes. Journal of
Immunology 156:3638-3644 (1996). 95. Li, J., D. Rosen, D. Ronen, C.
Behrens, P. Krammer, W. Clark and G. Berke. The regulation of CD95 ligand expression
and function in CTL. Journal of Immunology 161:3943 (1998). 96. Jensen, E., Glass, A., Clark, W.,
Wing, E., Miller, J., Gregory, S. 1998. Fas (CD95)- dependent cell-mediated immunity to Listeria
monocytogenes. Infection
and Immunity 66:4143 97. Matloubian, M., M. Suresh, A. Glass,
M. Galvan, K. Chow, J. Whitmore,
C. Walsh, Clark, W.R., and Ahmed, R. A role
for perforin in downregulating T- cell responses during chronic viral
infection. Journal of Virology
73:2527 (1999) 98. Berke, G. and W. Clark. 2004.
Cytotoxic T lymphocytes: Mechanism of action and role in allograft rejection. In, Immunology of Organ Transplantation. D. Wilkes and W.
Burlingham, eds. Kluwer Academic, Amsterdam. 99. Clark, W. 2004.
Reflections on an unsolved problem in biology: the evolution of senescence and
death. Advances in Gerontology 14:7 PUBLISHED ABSTRACTS
|